Goldman Sachs Group (GS)

What Happened? Shares of global investment bank Goldman Sachs (NYSE:GS) jumped 2.9% in the afternoon session after SpaceX made its market debut (the largest ...

Oil prices are declining amid hopes that the Strait of Hormuz will reopen soon.

What Happened? Shares of mediterranean fast-casual restaurant chain CAVA (NYSE:CAVA) jumped 2.6% in the afternoon session after the company raised its new re...

One of the ETFs has averaged annual gains of 16.4% over the past 15 years.

Applied Digital is successfully transitioning into a premier digital infrastructure landlord by securing massive hyperscaler commitments for its data centers.

Compare fees, risk profiles, and sector coverage between these two funds to see how their strategies could impact your investment approach.

Executives at argenex (NASDAQ:ARGX) told investors at a Goldman Sachs healthcare event that they continue to see meaningful growth opportunities for VYVGART across myasthenia gravis and chronic inflammatory demyelinating polyneuropathy, while also pointing to a busy slate of pipeline readouts in the

SpaceX needs to capitalize on one key opportunity to justify its IPO valuation.

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Strategy (NASDAQ:MSTR) and it...

Any combination is possible. There's one particular one, however, that just makes good logistical and geographic sense.

Bloom Energy's share price has lost nearly a quarter of its value from the recent peak.

Capricor Therapeutics (NASDAQ:CAPR) executives said the company is in active discussions with the U.S. Food and Drug Administration as it works toward a potential approval decision for deramiocel, its allogeneic cardiac-derived cell therapy for Duchenne muscular dystrophy. Speaking at a Goldman Sac

BrightSpring Health Services (NASDAQ:BTSG) Chief Financial Officer Jennifer Phipps said the company’s recent growth has been driven by broad-based performance across its pharmacy and provider businesses, with specialty pharmacy remaining a key contributor. Speaking at a Goldman Sachs healthcare ser

SpaceX will debut on the public markets, having raised at least $75 billion at a valuation of $1.78 trillion, making it the largest initial public offering ever.

Apogee Therapeutics (NASDAQ:APGE) executives outlined plans to advance zumilokibart, the company’s IL-13-targeting antibody, into late-stage development for atopic dermatitis while expanding the program into asthma and eosinophilic esophagitis, during a Goldman Sachs discussion hosted by lead biotec

Amylyx Pharmaceuticals (NASDAQ:AMLX) Co-Chief Executive Officer Justin Klee said the company is preparing for a key Phase 3 readout for avexitide, its lead program for post-bariatric hypoglycemia, during an appearance at the Goldman Sachs Global Healthcare Conference. Klee described avexitide as a

What Happened? A number of stocks jumped in the afternoon session after the CPI data showed food away from home rose only 0.3% in May, well within manageable...

What Happened? A number of stocks jumped in the afternoon session after the CPI data showed food away from home rose only 0.3% in May, well within manageable...

What Happened? A number of stocks jumped in the afternoon session after markets rotated into defensive names following the release of the May CPI report. The...

What Happened? A number of stocks jumped in the afternoon session after markets rotated into defensive names following the release of the May CPI report. The...

What Happened? A number of stocks jumped in the afternoon session after markets rotated into defensive names following the release of the May CPI report. The...